A Newly Synbiotic Combination Alleviates Obesity by Modulating the Gut Microbiota –Fat Axis and Inhibiting the Hepatic TLR4/NF‐κB Signaling Pathway
ConclusionThe synbiotic may be an effective candidate treatment strategy for the clinical prevention and treatment of obesity and other associated metabolic diseases such as hyperlipidemia, nonalcoholic fatty liver diseases by alleviating inflammatory response, regulating energy metabolism and maintaining the balance of intestinal microecology.
Source: Molecular Nutrition and Food Research - Category: Food Science Authors: Yongbo Kang,
Peng Ren,
Xiaorong Shen,
Xiaoyu Kuang,
Xiaodan Yang,
Haixia Liu,
Huan Yan,
Hao Yang,
Xing Kang,
Zeyuan Ding,
Xuguang Luo,
Jieqiong Ma,
Ying Yang,
Weiping Fan Tags: Research Article Source Type: research
More News: Acidophilus | Alternative and Complementary Therapies | Diets | Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Food Science | High Fat | International Medicine & Public Health | Lactobacillus Acidophilus | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Obesity | Probiotics | Study | Sugar | Urology & Nephrology